The store will not work correctly when cookies are disabled.
7-(3-(Aminomethyl)-4-ethylphenyl)-4-methylquinolin-2-amine
ID: ALA4527163
PubChem CID: 155544238
Max Phase: Preclinical
Molecular Formula: C19H21N3
Molecular Weight: 291.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1ccc(-c2ccc3c(C)cc(N)nc3c2)cc1CN
Standard InChI: InChI=1S/C19H21N3/c1-3-13-4-5-14(9-16(13)11-20)15-6-7-17-12(2)8-19(21)22-18(17)10-15/h4-10H,3,11,20H2,1-2H3,(H2,21,22)
Standard InChI Key: XEKHNHNHDNWKRZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
22.3228 -19.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3216 -20.5105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0338 -20.9236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0320 -19.2780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7447 -19.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7455 -20.5064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4582 -20.9176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1706 -20.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1658 -19.6764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4526 -19.2730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6095 -20.9227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.0296 -18.4608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8763 -20.9044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8789 -21.7227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5785 -20.4930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2865 -20.8907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2971 -21.7146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5888 -22.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9891 -20.4734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7018 -20.8732 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0087 -22.1164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0165 -22.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 11 1 0
4 12 1 0
13 14 2 0
14 18 1 0
15 13 1 0
8 13 1 0
15 16 2 0
16 17 1 0
17 18 2 0
16 19 1 0
19 20 1 0
17 21 1 0
21 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.40 | Molecular Weight (Monoisotopic): 291.1735 | AlogP: 3.81 | #Rotatable Bonds: 3 |
Polar Surface Area: 64.93 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.24 | CX LogP: 4.14 | CX LogD: 2.23 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.77 | Np Likeness Score: -0.23 |
References
1. Cinelli MA, Reidl CT, Li H, Chreifi G, Poulos TL, Silverman RB.. (2020) First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate., 63 (9): [PMID:32302123] [10.1021/acs.jmedchem.9b01573] |